Year |
Citation |
Score |
2023 |
Omidvari N, Jones T, Price PM, Ferre AL, Lu J, Abdelhafez YG, Sen F, Cohen SH, Schmiedehausen K, Badawi RD, Shacklett BL, Wilson I, Cherry SR. First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody. Science Advances. 9: eadh7968. PMID 37824612 DOI: 10.1126/sciadv.adh7968 |
0.632 |
|
2023 |
Omidvari N, Jones T, Price PM, Ferre AL, Lu J, Abdelhafez YG, Sen F, Cohen SH, Schmiedehausen K, Badawi RD, Shacklett BL, Wilson I, Cherry SR. First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody. Medrxiv : the Preprint Server For Health Sciences. PMID 36993568 DOI: 10.1101/2023.03.14.23287121 |
0.613 |
|
2021 |
SenGupta D, Brinson C, DeJesus E, Mills A, Shalit P, Guo S, Cai Y, Wallin JJ, Zhang L, Humeniuk R, Begley R, Geleziunas R, Mellors J, Wrin T, Jones N, ... ... Ferre AL, et al. The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy. Science Translational Medicine. 13. PMID 34162752 DOI: 10.1126/scitranslmed.abg3071 |
0.654 |
|
2020 |
Shacklett BL, Ferre AL, Kiniry BE. Defining T Cell Tissue Residency in Humans: Implications for HIV Pathogenesis and Vaccine Design. Current Hiv/Aids Reports. PMID 32052270 DOI: 10.1007/S11904-020-00481-7 |
0.695 |
|
2019 |
Shacklett BL, Ferre AL, Kiniry BE. Tissue issues: mucosal T-cell responses in HIV-1 infection. Current Opinion in Hiv and Aids. 14: 100-107. PMID 30601239 DOI: 10.1097/Coh.0000000000000530 |
0.735 |
|
2018 |
Hughes SM, Ferre AL, Yandura SE, Shetler C, Baker CAR, Calienes F, Levy CN, Astronomo RD, Shu Z, Lentz GM, Fialkow M, Kirby AC, McElrath MJ, Sinclair E, Rohan LC, et al. Cryopreservation of human mucosal tissues. Plos One. 13: e0200653. PMID 30059507 DOI: 10.1371/Journal.Pone.0200653 |
0.591 |
|
2016 |
Hughes SM, Shu Z, Levy CN, Ferre AL, Hartig H, Fang C, Lentz G, Fialkow M, Kirby AC, Adams Waldorf KM, Veazey RS, Germann A, von Briesen H, McElrath MJ, Dezzutti CS, et al. Cryopreservation of Human Mucosal Leukocytes. Plos One. 11: e0156293. PMID 27232996 DOI: 10.1371/Journal.Pone.0156293 |
0.663 |
|
2016 |
Ganesh A, Lemongello D, Lee E, Peterson J, McLaughlin B, Ferre AL, Gillespie G, Fuchs D, Deeks SG, Hunt PW, Price RW, Spudich S, Shacklett BL. Immune Activation and HIV-Specific CD8+ T-cells in Cerebrospinal Fluid of HIV Controllers and Non-Controllers. Aids Research and Human Retroviruses. PMID 27019338 DOI: 10.1089/Aid.2015.0313 |
0.763 |
|
2014 |
Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, Ferre AL, Hayes TL, Somsouk M, Hsue PY, Van Natta ML, Meinert CL, Lederman MM, Hatano H, Jain V, et al. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. Plos Pathogens. 10: e1004078. PMID 24831517 DOI: 10.1371/Journal.Ppat.1004078 |
0.667 |
|
2013 |
Hatano H, Yukl SA, Ferre AL, Graf EH, Somsouk M, Sinclair E, Abdel-Mohsen M, Liegler T, Harvill K, Hoh R, Palmer S, Bacchetti P, Hunt PW, Martin JN, McCune JM, et al. Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. Plos Pathogens. 9: e1003691. PMID 24130489 DOI: 10.1371/Journal.Ppat.1003691 |
0.713 |
|
2011 |
Shacklett BL, Ferre AL. Mucosal immunity in HIV controllers: the right place at the right time. Current Opinion in Hiv and Aids. 6: 202-7. PMID 21399497 DOI: 10.1097/Coh.0B013E3283453E2B |
0.722 |
|
2010 |
Ferre AL, Hunt PW, McConnell DH, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL. HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses. Journal of Virology. 84: 11020-9. PMID 20719952 DOI: 10.1128/Jvi.00980-10 |
0.756 |
|
2010 |
Ferre AL, Lemongello D, Hunt PW, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers. Journal of Virology. 84: 10354-65. PMID 20668079 DOI: 10.1128/Jvi.00803-10 |
0.759 |
|
2009 |
Ferre AL, Hunt PW, Critchfield JW, Young DH, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood. 113: 3978-89. PMID 19109229 DOI: 10.1182/Blood-2008-10-182709 |
0.756 |
|
2009 |
Shacklett BL, Critchfield JW, Ferre AL, Hayes TL. Mucosal T-cell responses to HIV: responding at the front lines. Journal of Internal Medicine. 265: 58-66. PMID 19093960 DOI: 10.1111/J.1365-2796.2008.02042.X |
0.763 |
|
2008 |
Emu B, Sinclair E, Hatano H, Ferre A, Shacklett B, Martin JN, McCune JM, Deeks SG. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control Journal of Virology. 82: 5398-5407. PMID 18353945 DOI: 10.1128/Jvi.02176-07 |
0.734 |
|
Show low-probability matches. |